Literature DB >> 3527460

Liposome-cell interactions: in vitro discrimination of uptake mechanism and in vivo targeting strategies to mononuclear phagocytes.

A J Schroit, J Madsen, R Nayar.   

Abstract

The interactions of liposomes with cells have been extensively studied to determine their potential use as vehicles for the delivery of drugs in vivo. Since intravenously administered liposomes are, for the most part, cleared by cells of the reticuloendothelial system (RES), considerable effort has been made to take advantage of this phenomenon rather than view it as an obstacle. Indeed, cells of the RES, in particular macrophages, have been shown to play a vital role in homeostasis and in host defence mechanisms against infection and neoplasia. In this article, we present an overview of liposome-cell interactions, with particular emphasis on the techniques used to monitor the interaction of liposomes with macrophages. Specifically, we discuss methodologies which can be used to differentiate between liposome-cell fusion, adsorption and endocytosis in vitro. In addition, we outline the various strategies that have been employed for both actively and passively targeting liposomes to macrophages in vivo. We also review the rationale and various techniques for designing liposomes for enhanced macrophage uptake, which, in certain cases, results in the selective release of liposome-entrapped compounds in situ.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3527460     DOI: 10.1016/0009-3084(86)90080-0

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  13 in total

Review 1.  Biodegradable nanoparticles for cytosolic delivery of therapeutics.

Authors:  Jaspreet K Vasir; Vinod Labhasetwar
Journal:  Adv Drug Deliv Rev       Date:  2007-06-26       Impact factor: 15.470

2.  Host factors influencing the preferential localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue.

Authors:  R M Schiffelers; G Storm; I A Bakker-Woudenberg
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

3.  Liposomal simvastatin attenuates neointimal hyperplasia in rats.

Authors:  Eyal Afergan; Meital Ben David; Hila Epstein; Nickolay Koroukhov; Dalia Gilhar; Keren Rohekar; Haim D Danenberg; Gershon Golomb
Journal:  AAPS J       Date:  2010-02-09       Impact factor: 4.009

Review 4.  Controlling subcellular delivery to optimize therapeutic effect.

Authors:  Mohanad Mossalam; Andrew S Dixon; Carol S Lim
Journal:  Ther Deliv       Date:  2010-07

Review 5.  Canonical and non-canonical barriers facing antimiR cancer therapeutics.

Authors:  Christopher J Cheng; W Mark Saltzman; Frank J Slack
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

6.  Formulation and pharmacokinetics of thermosensitive stealth® liposomes encapsulating 5-Fluorouracil.

Authors:  Chantal Al Sabbagh; Nicolas Tsapis; Anthony Novell; Patricia Calleja-Gonzalez; Jean-Michel Escoffre; Ayache Bouakaz; Hélène Chacun; Stéphanie Denis; Juliette Vergnaud; Claire Gueutin; Elias Fattal
Journal:  Pharm Res       Date:  2014-11-22       Impact factor: 4.200

7.  Nanoparticle-based evaluation of blood-brain barrier leakage during the foreign body response.

Authors:  Andrew J Sawyer; Themis R Kyriakides
Journal:  J Neural Eng       Date:  2013-01-21       Impact factor: 5.379

Review 8.  Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.

Authors:  Phatsapong Yingchoncharoen; Danuta S Kalinowski; Des R Richardson
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

9.  Preparation of alendronate liposomes for enhanced stability and bioactivity: in vitro and in vivo characterization.

Authors:  Hila Epstein; Dikla Gutman; Einat Cohen-Sela; Elran Haber; Omar Elmalak; Nickolay Koroukhov; Haim D Danenberg; Gershon Golomb
Journal:  AAPS J       Date:  2008-10-21       Impact factor: 4.009

10.  Role of complements C3 and C5 in the phagocytosis of liposomes by human neutrophils.

Authors:  J F Scieszka; L L Maggiora; S D Wright; M J Cho
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.